RecruitingPhase 1NCT07855133
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
Sponsor: Novo Nordisk A/S
Glendale, CA · +1 more sites